Inventor · disambiguated record
Mohamed Lamkanfi
Also filed as: LAMKANFI MOHAMED
0 granted patents·14 pending applications·0 citations·filing 2005–2022
Top patents by PatentIndex Score
14 records- 0160US2024279223A15-oxo-pyrido[2,3-d]pyridazin-6(5h)-yl acetamidesJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 0259US2024239757A1Phthalazinone derivates as nlrp3 inflammasome inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 0358US2024109905A14-alkoxy-6-oxo-pyridazine derivatives modulating nlrp3JANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 0458US2024174670A14-amino-6-oxo-pyridazine derivatives modulating nlrp3JANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 0557US2023391756A1New compoundJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 0656US2023183248A1Pyrrolo[1,2-d][1,2,4]triazine-2-yl-acetamides as inhibitors of the nlrp3 inflammasome pathwayJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 0756US2024043450A1New compoundJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 0856US2023203044A1Pyrazolo[1,5-d][1,2,4]triazine-5(4h)-acetamides as inhibitors of the nlrp3 inflammasomeJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 0955US2023183249A1New triazinoindole compoundsJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 1055US2023202989A1CompoundsJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 1154US2023203064A1Tricyclic compounds as inhibitors of nlrp3JANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 1252US2022275069A1Binding agents and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2020·Application pending·0 cites
- 1339US2021079444A1Label free detection of protease activityVIB VZW·Filed 2018·Application pending·0 cites
- 1439US2008108546A1Novel Human Card-Only Protein That Inhibits Pro-Il-1 Beta MaturationVLAAMS INTERUNIV INST BIOTECH·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mohamed Lamkanfi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →